A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dow Pharmaceutical Sciences
• Treatments: Benzoyl Peroxide; Clindamycin; Clindamycin palmitate; Clindamycin phosphate

Criteria

Inclusion Criteria:

• Presence of inflammatory and non-inflammatory lesions

Exclusion Criteria:

• Dermatological conditions of the face other than acne that could interfere with clinical evaluations

• Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study